Antibody-drug conjugate characterization by chromatographic and electrophoretic techniques

被引:55
|
作者
Chen, Tao [1 ]
Chen, Yan [2 ]
Stella, Cinzia [2 ]
Medley, Colin D. [1 ]
Gruenhagen, Jason A. [1 ]
Zhang, Kelly [1 ]
机构
[1] Genentech Inc, Small Mol Pharmaceut Sci, 1 DNA Way, San Francisco, CA 94080 USA
[2] Genentech Inc, Prot Analyt Chem, 1 DNA Way, San Francisco, CA 94080 USA
关键词
Antibody drug conjugate (ADC); Critical quality attribute (CQA); Drug-to-antibody ratio (DAR); Drug distribution; Peptide mapping; Charge variants; Aggregations; Free drug analysis; PERFORMANCE LIQUID-CHROMATOGRAPHY; MOLECULAR-SIEVE CHROMATOGRAPHY; SIZE-EXCLUSION CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; ACUTE MYELOID-LEUKEMIA; MONOCLONAL-ANTIBODY; STRUCTURAL-CHARACTERIZATION; CAPILLARY-ELECTROPHORESIS; PHYSICOCHEMICAL STABILITY; CALICHEAMICIN CONJUGATE;
D O I
10.1016/j.jchromb.2016.07.023
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Due to the inherent structure complexity and component heterogeneity of antibody drug conjugates (ADCs), separation technologies play a critical role in their characterization. In this review, we focus on chromatographic and electrophoretic approaches used to characterize ADCs with respect to drug to-antibody ratio, drug distribution and conjugation sites, free small molecule drugs, charge variants, aggregates and fragments, etc. Chromatographic techniques including reversed-phase, ion exchange, size exclusion, hydrophobic interaction, two-dimensional liquid chromatography, and gas chromatography as well as capillary electrophoretic techniques including capillary electrophoresis sodium dodecyl sulfate, capillary zone electrophoresis and capillary isoelectric focusing are reviewed for their applications in the characterization of ADCs. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:39 / 50
页数:12
相关论文
共 50 条
  • [1] Antibody-Drug Conjugate Targets
    Teicher, B. A.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (08) : 982 - 1004
  • [2] An Immunosuppressive Antibody-Drug Conjugate
    Wang, Rongsheng E.
    Liu, Tao
    Wang, Ying
    Cao, Yu
    Du, Jintang
    Luo, Xiaozhou
    Deshmukh, Vishal
    Kim, Chan Hyuk
    Lawson, Brian R.
    Tremblay, Matthew S.
    Young, Travis S.
    Kazane, Stephanie A.
    Wang, Feng
    Schultz, Peter G.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (09) : 3229 - 3232
  • [3] The antibody-drug conjugate landscape
    Flynn, Patrick
    Suryaprakash, Smruthi
    Grossman, Dan
    Panier, Val
    Wu, John
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (08) : 577 - 578
  • [4] Novel antibody-drug conjugate characterization by LC-MS
    不详
    BIOANALYSIS, 2011, 3 (15) : 1685 - 1685
  • [5] Antibody-drug conjugate for advanced melanoma?
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2014, 15 (12): : E534 - E534
  • [6] Sacituzumab govitecan: an antibody-drug conjugate
    Sahota, Sheena
    Vahdat, Linda T.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (08) : 1027 - 1031
  • [7] Antibody-drug conjugate in multiple myeloma
    Guillaume, Escure
    Manier, Salomon
    HEMATOLOGIE, 2021, 27 : 26 - 34
  • [8] Year in review: Antibody-drug conjugate
    Sato, Jun
    CANCER SCIENCE, 2024, 115 : 1459 - 1459
  • [9] Antibody-drug conjugate for ovarian cancer
    Collingridge, David
    LANCET ONCOLOGY, 2020, 21 (07): : 886 - 886
  • [10] Antibody-Drug Conjugate to Treat Meningiomas
    Chen, Kai
    Si, Yingnan
    Ou, Jianfa
    Guan, Jia-Shiung
    Kim, Seulhee
    Ernst, Patrick
    Zhang, Ya
    Zhou, Lufang
    Han, Xiaosi
    Liu, Xiaoguang
    PHARMACEUTICALS, 2021, 14 (05)